Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: J Comp Neurol. 2010 Nov 1;518(21):4375–4394. doi: 10.1002/cne.22462

Figure 9.

Figure 9

Plasma hormone levels following administration of TIP39 with or without glutamate receptor blockers. A: Plasma corticosterone. B: Plasma prolactin. Treatment groups as defined in the legend to Figure 8. Significantly different from vehicle-treated animals, *P < 0.0006, #P < 0.01; ANOVA followed by Student-Neuman-Keuls test, n = 4–7/group.